When Innovation And Access Diverge: Who Pays For India's First Dengue Vaccine?
The Central Drugs Standard Control Organisation approved Qdenga for use in India, making it the country's first dengue vaccine, following licensing in over 40 countries and WHO prequalification. The approval comes amid some of India's worst recent dengue years and growing concern that Takeda's tiered global pricing could leave dense urban slums and migrant communities unable to afford it.